Date Announced: 07 Aug 2018
Experience the cloud-based platform at M&M expo, booth 624, in Baltimore, MD, USA.
Photo, right: ZEISS showcases APEER at M&M in Baltimore: easy-to-use modules and workflows can be combined into personalized end-to-end solutions that enhance research.
Jena, Germany -- ZEISS is presenting the initial release of its cloud-based digital microscopy platform, known under the name APEER at the Microscopy & Microanalysis conference (M&M) in Baltimore, USA. Microscopy users will be able to automatically process images in the cloud by leveraging application workflows for 3D reconstructions, staining or segmenting.
Use cases at M&M demonstrate different workflows, from the acquisition of images to particle analysis and reporting. In addition to enabling the exchange of scientific applications on the platform, the plan is to promote collaboration between scientists and provide community-building functions, such as a discussion forum and the opportunity to swap data sets or build on existing workflows.
Dr. Markus Weber, Head of the Microscopy business group, highlights APEER’s unique features: "With APEER, we are giving researchers the opportunity to concentrate more on their work and less on image processing by providing them with all the tools necessary to collaborate and build solutions for their specific research needs."
Matthias Gohl, Head of the Digital Innovation Partners, ZEISS' own, in-house competence center for digital transformation founded in 2016, adds: "Digitalization offers a wide range of opportunities for groundbreaking innovations, and this is where APEER will play an important role. ZEISS also aspires to offer leading technologies and solutions for users working in a variety of different areas, ranging from research and academia to industry."
A broad network of developers and test users from the field of scientific microscopy were involved in shaping the initial release. APEER is being gradually made available to scientific institutions and the industry: www.apeer.com
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and semiconductor manufacturing equipment.
With its solutions, the company constantly advances the world of optics and helps shape technological progress. ZEISS is divided up into the four segments Research & Quality Technology, Medical Technology, Vision Care/Consumer Products and Semiconductor Manufacturing Technology. The ZEISS Group is represented in more than 40 countries and has over 50 sales and service locations, more than 30 manufacturing sites and about 25 research and development centers around the globe.
In fiscal year 2016/17 the company generated revenue approximating €5.3 billion with around 27,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).
Web Site: www.zeiss.com/med